Table 1.
Clinical characteristics of patients with cervical squamous cell carcinoma
| Clinical characteristics | NACT group (n = 64) | Conventional group (n = 39) | t/χ2 | P | Chemotherapy-insensitive group (n = 33) | Chemotherapy-sensitive group (n = 31) | t/χ2 | P |
|---|---|---|---|---|---|---|---|---|
| Age | 47.25 ± 8.45 | 47.97 ± 8.23 | − 0.422 | 0.674 | 47.30 ± 6.83 | 47.19 ± 10.00 | 0.051 | 0.960 |
| Pathological grade | 0.840 | 0.657 | 6.142 | 0.057 | ||||
| G1 | 16 (25.0) | 13 (33.3) | 7 (21.2) | 9 (29.0) | ||||
| G2 | 41 (64.1) | 22 (56.4) | 25 (75.8) | 16 (51.6) | ||||
| G3 | 7 (10.9) | 4 (10.3) | 1 (3.0) | 6 (19.4) | ||||
| Lymph nodes | 1.114 | 0.391 | 1.502 | 0.220 | ||||
| Positive | 26 (40.6) | 20 (51.3) | 11 (33.3) | 15 (48.4) | ||||
| Negative | 38 (59.4) | 19 (48.7) | 22 (66.7) | 16 (51.6) | ||||
| The number of positive lymph nodes | 1.0 (1.0, 4.0) | 1.0 (1.0, 3.0) | −0.012 | 0.991 | 1.0 (1.0, 3.0) | 1.0 (1.0, 4.0) | −0.339 | 0.734 |
| FIGO | 3.232 | 0.072 | 0.119 | 0.730 | ||||
| Ib2 | 22 (34.4) | 7 (17.9) | 12 (36.4) | 10 (32.3) | ||||
| IIA2 | 42 (65.6) | 32 (82.1) | 21 (63.6) | 21 (67.7) | ||||
| Lesion size | 5.10 ± 1.40 | 5.12 ± 0.74 | −0.061 | 0.944 | 4.86 ± 1.47 | 5.36 ± 1.31 | −1.419 | 0.161 |